DIA Biosimilars 2013

CROs/Service Providers

DKSH divests contract manufacturing plant OLIC to Fuji Pharma

Wednesday, August 8, 2012 10:47 AM

DKSH, a market expansion services provider with a focus on Asia, has agreed to divest OLIC, a contract manufacturing operation of pharmaceutical products in Thailand, to Fuji Pharma of Japan. The transaction is subject to customary closing conditions.

More... »

Cenduit: Now with Patient Reminders

Icon to expand hospital-based presence in translational medicine

Wednesday, August 8, 2012 10:26 AM

Icon, a global provider of outsourced development services, has announced plans to further expand its U.K. hospital-based presence on the Manchester Royal Infirmary Campus.

More... »

CRF Health – eCOA Forum

Theorem and Gallus ink exclusive partnership

Wednesday, August 8, 2012 10:15 AM

Theorem Clinical Research, a global provider of comprehensive clinical research and development services, has entered an exclusive partnership with Gallus BioPharmaceuticals, a contract manufacturing company based in St. Louis, Mo., to help both companies accelerate their research, development and manufacturing of biopharmaceuticals.

More... »

Mission Search to provide commissioning services for Sensus Healthcare

Wednesday, August 8, 2012 10:01 AM

Mission Search, a Tampa, Fla.-based healthcare search and staffing organization, is has joined forces with Sensus Healthcare, a Boca Raton, Fla.-based company focused on skin cancers, to provide commissioning services to Sensus’ clientele.

More... »

German CRO Verum.de opens U.S. office

Wednesday, August 8, 2012 09:24 AM

Verum.de, a German-based CRO, has opened a new office in Carlsbad, Calif.

More... »

Teva Canada completes sale of Mirabel facility to Halo Pharmaceutical

Monday, August 6, 2012 11:38 AM

Teva Canada, a healthcare solutions provider, has completed the sale of its Mirabel manufacturing facility in Montreal to Halo Pharmaceutical, a contract development and manufacturing organization (CDMO) based in Parsippany, N.J.

More... »

Accenture to acquire Octagon Research Solutions

Friday, August 3, 2012 02:40 PM

Accenture, a global management consulting, technology services and outsourcing company, has agreed to acquire Octagon Research Solutions, a Wayne, Penn.-based provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. Terms of the transaction were not disclosed.

More... »

Burrill & Company closes second Burrill Capital Fund IV

Friday, August 3, 2012 02:32 PM

Burrill & Company, a global life sciences financial services firm, announced a second close of its Burrill Capital Fund IV, bringing the aggregate capital commitments to $505 million.

More... »

Covidien opens $45M R&D facility in China

Thursday, August 2, 2012 02:30 PM

Covidien, a global provider of healthcare products, has officially opened its China Technology Center (CTC) Research and Development (R&D) facility in Shanghai.

More... »

Hologic completes acquisition of Gen-Probe

Thursday, August 2, 2012 02:17 PM

Hologic, a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products, has completed its acquisition of Gen-Probe, a developer of nucleic acid tests, for approximately $3.8 billion. Gen-Probe is now a wholly-owned subsidiary of Hologic.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs